1. Home
  2. HOWL vs VELO Comparison

HOWL vs VELO Comparison

Compare HOWL & VELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • VELO
  • Stock Information
  • Founded
  • HOWL 2017
  • VELO 2014
  • Country
  • HOWL United States
  • VELO United States
  • Employees
  • HOWL N/A
  • VELO N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • VELO Industrial Machinery/Components
  • Sector
  • HOWL Health Care
  • VELO Technology
  • Exchange
  • HOWL Nasdaq
  • VELO Nasdaq
  • Market Cap
  • HOWL 64.5M
  • VELO 63.7M
  • IPO Year
  • HOWL 2021
  • VELO N/A
  • Fundamental
  • Price
  • HOWL $1.56
  • VELO $5.48
  • Analyst Decision
  • HOWL Strong Buy
  • VELO Strong Buy
  • Analyst Count
  • HOWL 5
  • VELO 1
  • Target Price
  • HOWL $7.20
  • VELO $6.00
  • AVG Volume (30 Days)
  • HOWL 1.3M
  • VELO 1.2M
  • Earning Date
  • HOWL 11-14-2025
  • VELO 11-26-2025
  • Dividend Yield
  • HOWL N/A
  • VELO N/A
  • EPS Growth
  • HOWL N/A
  • VELO N/A
  • EPS
  • HOWL N/A
  • VELO N/A
  • Revenue
  • HOWL N/A
  • VELO $43,765,000.00
  • Revenue This Year
  • HOWL N/A
  • VELO $30.60
  • Revenue Next Year
  • HOWL N/A
  • VELO $57.71
  • P/E Ratio
  • HOWL N/A
  • VELO N/A
  • Revenue Growth
  • HOWL N/A
  • VELO N/A
  • 52 Week Low
  • HOWL $0.60
  • VELO $1.43
  • 52 Week High
  • HOWL $2.96
  • VELO $29.25
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 45.71
  • VELO N/A
  • Support Level
  • HOWL $1.55
  • VELO N/A
  • Resistance Level
  • HOWL $1.83
  • VELO N/A
  • Average True Range (ATR)
  • HOWL 0.13
  • VELO 0.00
  • MACD
  • HOWL -0.03
  • VELO 0.00
  • Stochastic Oscillator
  • HOWL 14.71
  • VELO 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About VELO Velo3D Inc. Common stock

Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.

Share on Social Networks: